GLYCEMIC OUTCOMES OF REAL-WORLD MINIMED™ 780G SYSTEM USERS FROM LATIN AMERICA

被引：0
|
作者：
Castro, M. [1 ]
Van Den Heuvel, T. [2 ]
Arrieta, A. [3 ]
Castaneda, J. [3 ]
Grassi, B. [4 ]
Medina, A. Gomez [5 ]
Calliari, L. E. [6 ]
Denise, F. [7 ]
Raggio, M. [8 ]
Cohen, O. [9 ]
机构：
[1] Medtron LATAM, Diabet, Santiago, Chile
[2] Bakken Res Ctr, Medtron Diabet, Maastricht, Netherlands
[3] Medtron Bakken Res Ctr, Medtron Diabet Emea, Maastricht, Netherlands
[4] Pontificia Univ Catolica Chile, Nutr Diabet & Metab, Santiago, Chile
[5] Hosp Univ San Ignacio, Endocrinol Unit, Bogota, Colombia
[6] Santa Casa Sao Paulo Sch Med Sci, Pediat Endocrinol Unit, Sao Paulo, Brazil
[7] CPCLIN DASA Clin Res Ctr, Dept Diabet, Sao Paulo, Brazil
[8] Hosp Univ Austral, Hosp Materno Infantil Tigre, Buenos Aires, Argentina
[9] Medtron Int Trading Sarl, Medtron Diabet Emea, Tolochenaz, Switzerland
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
900
引用
收藏
页码：A108 / A109
页数：2
相关论文
共 50 条
  • [21] Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
    Jothydev Kesavadev
    Anjana Basanth
    Gopika Krishnan
    Arun Shankar
    Geethu Sanal
    Sunitha Jothydev
    Diabetes Therapy, 2023, 14 : 1319 - 1330
  • [22] THE SIGNIFICANCE OF COEFFICIENT OF VARIATION AS A MEASURE OF HYPOGLYCEMIA RISK AND TIME IN RANGE IN REAL WORLD USERS OF THE MINIMED™ 780G SYSTEM
    Castaneda, J.
    Van Den Heuvel, T.
    Arrieta, A.
    Cohen, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A235 - A235
  • [23] The use of optimal system settings in real-world MiniMed 780G system users has a large impact on increasing the time in tight glucose range
    Castaneda, J.
    van den Heuvel, T.
    Arrieta, A.
    Cohen, O.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S118 - S119
  • [24] Glycemic Outcomes after Six Months of Real-World MiniMed 780G Advanced Hybrid Closed-Loop (AHCL) Therapy Use in Chile
    Castro, Matias
    Bonilla, Camila Nicole Carrasco
    Macedo, Joana C. Leon
    Gutierrez, Maria Fernanda
    Lopez, Zeudi C. Valera
    Daghero, Andrea
    DIABETES, 2022, 71
  • [25] Time in Tight Glucose Range in Type 1 Diabetes: Predictive Factors and Achievable Targets in Real-World Users of the MiniMed 780G System
    Castaneda, Javier
    Arrieta, Arcelia
    van den Heuvel, Tim
    Battelino, Tadej
    Cohen, Ohad
    DIABETES CARE, 2024, 47 (05) : 790 - 797
  • [26] Safety and Glycemic Outcomes Using the MiniMed 780G System with a Disposable All-in-One Sensor with Transmitter
    Forlenza, Gregory P.
    MacLeish, Sarah A.
    Shulman, Dorothy I.
    Nwosu, Benjamin U.
    Accacha, Siham
    Garg, Satish K.
    Carlson, Anders L.
    Castorino, Kristin N.
    Marks, Brynn E.
    Lal, Rayhan
    Pihoker, Catherine
    Thrasher, James
    Laffel, Lori M.
    Sunil, Bhuvana
    Bode, Bruce W.
    Sherr, Jennifer L.
    Ekhlaspour, Laya
    Reed, John H.
    Abuzzahab, M. Jennifer
    Church, Mei Mei
    Dai, Zheng
    Ma, Haoxi
    Solomon, Jed
    Treminio, Yuri
    Shin, John
    Rhinehart, Andrew S.
    McVean, Jennifer
    Vigersky, Robert A.
    DIABETES, 2024, 73
  • [27] Higher Real-World Time in Range Demonstrated in Children Using Recommended MiniMed 780G (AHCL) Settings
    Mcvean, Jennifer
    Arrieta, Arcelia
    Cordero, Toni L.
    Castro, Matias
    Castaneda, Javier
    Cohen, Ohad
    DIABETES, 2023, 72
  • [28] The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan
    Al-Sofiani, Mohammed E.
    Petrovski, Goran
    Al Shaikh, Abdulrahman
    Alguwaihes, Abdullah
    Al Harbi, Mohammad
    Al Mohannadi, Dabia
    Adjene, Alero
    Alagha, Abdulmoeen
    Al Remeithi, Sareea
    Alamuddin, Naji
    Arrieta, Arcelia
    Castaneda, Javier
    Chaar, Wael
    van den Heuvel, Tim
    Cohen, Ohad
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 937 - 949
  • [29] The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system
    Castaneda, Javier
    Arrieta, Arcelia
    van den Heuvel, Tim
    Cohen, Ohad
    DIABETES OBESITY & METABOLISM, 2023, 25 (09): : 2545 - 2552
  • [30] GLYCEMIC OUTCOMES AND SAFETY WITH MINIMED 780G SYSTEM IN CHILDREN WITH TYPE 1 DIABETES AGED 2-6 YEARS
    Tuomaala, A. -K.
    Varimo, T.
    Hakonen, E.
    Kiiveri, S.
    Janer, J.
    Hyvonen, M.
    Wehkalampi, K.
    Laakkonen, H.
    Laakso, S.
    Harsunen, M.
    Hero, M.
    Miettinen, P.
    Pulkkinen, M. -A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A82 - A82
12345